Crs: Cytokine Release Syndrome () Update: Aptevo Therapeutics and Carpenter Technology
Aptevo Therapeutics has reported promising results in treating newly diagnosed AML patients without cytokine release syndrome. Meanwhile, Carpenter Technology’s stock shows significant growth.